Detalles de la búsqueda
1.
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865026
2.
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol;
2024 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38900215
3.
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38904887
4.
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol;
2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755516
5.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol;
29(6): 700-705, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38696053
6.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol;
29(6): 689-699, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578596
7.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(6): 681-688, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649648
8.
Efficacy, Safety and Quality of Life of Pegcetacoplan in Japanese Patients With Paroxysmal Nocturnal Hemoglobinuria Treated Within the Phase 3 PEGASUS Trial.
Acta Haematol;
2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615657
9.
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.
Int J Clin Oncol;
29(5): 535-544, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494578
10.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 551-558, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526621
11.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(5): 559-563, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538963
12.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol;
29(5): 545-550, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517658
13.
Predictive Model for Occurrence of Febrile Neutropenia after Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Retrospective, Observational Study.
Hematol Rep;
16(1): 76-88, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390940
14.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol;
29(4): 355-362, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353907
15.
Post-infarction Left Ventricular Free Wall Rupture Diagnosed by Contrast-Enhanced Computed Tomography: A Case Report.
Cureus;
16(1): e52127, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38344574
16.
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot® ) evaluated by global coagulation assay in patients with acquired haemophilia A.
Haemophilia;
30(1): 249-252, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031253
17.
Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor.
Pathology;
56(1): 81-91, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38110323
18.
Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report.
Hematol Rep;
15(4): 662-669, 2023 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38132275
19.
Clinical Characteristics and Diagnostic Prediction of Severe Fever with Thrombocytopenia Syndrome and Rickettsiosis in the Co-Endemic Wakayama Prefecture, Japan.
Medicina (Kaunas);
59(11)2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38004073
20.
Administration of combined venetoclax and azacitidine in a patient with acute myeloid leukemia and multiple comorbidities undergoing dialysis: A case report.
EJHaem;
4(3): 841-843, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601888